ANNA YANCEY: Open Payments
NPI 1801466719 · ROME, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,953 in 120 payments from 16 companies in 2025. Trend: 2023 $1,686 · 2024 $1,909 · 2025 $2,953
Food & beverage: $2,668Education: $285
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 16 | $473 |
| Janssen Biotech, Inc. | 18 | $377 |
| Novartis Pharmaceuticals Corporation | 10 | $287 |
| PFIZER INC. | 9 | $254 |
| Arcutis Biotherapeutics, Inc. | 8 | $250 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 18 | $249 |
| Regeneron Healthcare Solutions, Inc. | 7 | $201 |
| Lilly USA, LLC | 7 | $168 |
| ABBVIE INC. | 9 | $157 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $135 |
Products named: DUPIXENT, TREMFYA, Zoryve, COSENTYX, ILUMYA, CIBINQO, EBGLYSS, LITFULO.
Industry payments across GA — which companies pay providers there.
